与疾病相关的无意义和框架转移变体导致GluN2A或GluN2BC终端域的截断,降低NMDAR表面表达并减少神经类固醇的增强作用
Bohdan Kysilov1,2, Viktor Kuchtiak1,3, Barbora Hrcka Krausova1
1Laboratory of Cellular Neurophysiology, Institute of Physiology of the Czech Academy of Sciences, Videnska 1083, 14200, Prague 4, Czech Republic.
Cellular and molecular life sciences : CMLS
|January 12, 2024
概括
与疾病相关的N-甲基-D-酸盐受体 (NMDAR) 变体会损害大脑功能. 类固醇可以选择性地增强NMDAR功能,为神经精神疾病提供潜在的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- N-甲基-D-酸盐受体 (NMDARs) 对大脑功能至关重要.
- 在NMDAR子单元中的遗传变异与神经精神疾病有关.
研究的目的:
- 调查NMDARC终端域 (CTD) 截断因疾病相关变异引起的功能影响.
- 探索使用神经类固醇对这些变异性NMDARs的潜在治疗调制.
主要方法:
- 全细胞补丁电生理学 电生理学
- 光显微镜的光学显微镜.
- 在模拟模型.
- 类固醇应用 类固醇应用
主要成果:
- 截断的NMDARs表现出降低的表面表达,改变了激动剂亲和力,增加了无敏化,降低了通道开放概率.
- 自然存在的和合成类固醇差异性地增强截断的NMDARs的功能.
- 类固醇增强取决于CTD截断长度,受体子单元和GluN1拼接变异.
结论:
- 在NMDAR CTD中断显著破坏受体功能.
- 特定的神经类固醇可以选择性地调节截断的NMDARs的功能.
- 这些发现为开发针对NMDAR相关疾病的新型神经类固醇治疗方法提供了基础.
相关概念视频
Nonsense-mediated mRNA Decay
10.6K
The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
10.6K
Leaky Scanning
5.1K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K
Translation
14.9K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
14.9K
Mutations
82.4K
Overview
82.4K
RNA Splicing
56.4K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.4K
Nuclear Export of mRNA
7.7K
Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
7.7K


